Libifem® - phát kiến mới cho sức khỏe phụ nữ

Libifem® – New innovation for women's health

NutraIngredients USA honors the active ingredients, finished products, businesses and scientists with the best and brightest innovations in the field of nutrition and dietary supplements in the United States. Recently, NutraIngredients USA honored Libifem® in the category of New Innovation for Women's Health. Join Atlantic Medical to learn more about Libifem® to understand why Libifem® won this prestigious award in the article below. 

What is Libifem?

Fenugreek (Trigonella foenum-graecum) is a plant that grows about 2–3 feet (60–90 cm) tall. It has green leaves, small white flowers, and pods containing small yellow-brown seeds. For thousands of years, fenugreek has been used in Chinese medicine in remedies to treat skin conditions and many other diseases. Fenugreek seeds and powder are also used in many Indian dishes because of their nutritional content and slightly sweet, nutty taste. Modern medicine has also researched and found that natural fenugreek extract contains more than 100 different active ingredients and has diverse uses and many benefits to human health such as enhancing milk supply, lowering blood sugar, and reducing cancer. letters….  

Libifem® is a fenugreek seed extract standardized by Gencor Group, consisting of Furostanol Saponin and Steroidal Saponin. Clinically proven to have a positive impact on healthy libido and sexual arousal and to support the unpleasant manifestations of hormonal insufficiency (characterized by perimenopause, menopause) through through increasing estradiol and testosterone levels. 

Libifem® was developed by Gencor Group to support women's health throughout their lives by helping to minimize the natural aging process by helping to reduce the unpleasant manifestations of hormonal decline, supporting health and wellness. sexual health in women. The effectiveness of Libifem® is proven through RCT studies – the gold standard for demonstrating the effectiveness of a treatment. 

Reduced sexual desire is a common condition where 1 in 4 women has decreased sexual desire. Loss of libido can affect adult women of all ages, especially women after the age of 35. But in reality, on the market, there are very few options to help women effectively improve this condition. healthy, safe. Libifem® is a unique solution to enhance female hormones (estrogen, testosterone) to help increase vaginal lubrication, enhance desire, increase pleasure, and sexual experience. 

Hormonal decline Most common in premenopause, menopause or postpartum period. This is a natural biological process that can be accompanied by a variety of factors expression of discomfort (Hot flashes, sweaty stuff, drought…) These manifestations can affect women to varying degrees, vary from person to person and sometimes cause discomfort and distress. Libifem® has been shown to be effective in reducing some of these symptoms and supporting women's quality of life. 

Libifem®: Research on the unpleasant manifestations of hormonal insufficiency

A 12-week double-blind, randomized, placebo-controlled study evaluated the effects of Libifem® in reducing menopausal symptoms in 115 women (ages 40-65). 

  • Main outcome measure: Reduction of menopausal symptoms (MENQOL). 
  • Secondary outcome measures: Serum sex hormone levels and other quality of life questionnaires – DISF and FSFI (sexual function), PSI (sleep function) and IPAC (exercise). 
  • Results show that using 600mg Libifem® helps: 

+ 50% reduces the frequency of unpleasant manifestations of hormonal deficiency (hot flashes, night sweats) 

+ Significantly improve vasomotor, psychosocial, physical and sexual problems 

‍This study demonstrates that Libifem® can reduce the unpleasant symptoms of hormonal insufficiency and improve women's quality of life, with no adverse effects reported in users. 

Bằng chứng lâm sàng của Libifem®
Libifem® Clinical Evidence

Libifem®: Research on female sexual health

An 8-week double-blind, randomized, placebo-controlled study to evaluate the effects of Libifem® on female sex hormones and sexual function in 80 sexually active women aged 20-49 years. low sex. 

  • Sexual function was measured using the DISF-SR, which tests five domains of sexual function. 
  • Results show that using 300mg Libifem® helps: 

+ Increased estradiol 66% concentrations compared to the placebo group 

+ Increased testosterone 20% concentration compared to the placebo group 

+ Significantly increases desire and quality of sexual activity in a healthy way 

Bằng chứng lâm sàng của Libifem®
Libifem® Clinical Evidence

This study indicates that Libifem® may be a useful option for increasing sexual arousal and desire in women and no adverse effects were observed in users. 

Award "New innovation for women's health 2023"

With convincing results from the two RCTs mentioned above, Libifem has won a series of awards and recognition. 

In 2013, Libifem® was rated as ““Most Novel Ingredient” when attending Natural Products Expo West. Libifem® is also recognized with a patent by the United States, Europe, and Canada due to its great uses for women's health.  

In 2023, Libifem® won convincingly in the category category Innovations in Women's Health Award – New innovations for women's health by NutraIngredients USA. In considering the “New Innovation for Women's Health” award, the NutraIngredients USA Jury said: “Two double-blind, randomized, placebo-controlled studies of Libifem® report truly profound benefits attracted the attention of the jury." As one judge commented, “few products can help improve women's sexual health, but one product is effective in both improving sexual health and reducing symptoms of premenopausal discomfort. Truly outstanding" 

If you have any questions, please pick up the phone and contact us immediatelyHotline 0936.236.283or leave a questionherefor answers and advice from Atlantic Medical's pharmacists 

Wishing you and your family good health and quality life! 

See all

New post:

Sign up for health consultation

Check your female hormone status

Related articles

[…]

...